Home » Topics » BioWorld Science

BioWorld Science
RSS

5-HT7 antagonists patented by KAIST, KIST

June 20, 2019

Step Pharma discovers new CTP synthase 1 inhibitors

June 20, 2019

Abatacept misses primary endpoint in Sjogren's syndrome in phase III study

June 20, 2019

Durvalumab in combination with R-CHOP shows promising response rates in high-risk DLBCL

June 20, 2019

Apatinib monotherapy shows promising efficacy and manageable toxicities in mCRC

June 20, 2019

Updated positive results for phase Ib study of resiniferatoxin in knee osteoarthritis pain

June 20, 2019

Positive early safety and efficacy results of phase I/II study of nomacopan in AKC

June 20, 2019

Arch Biopartners initiates phase I study of Metablok

June 20, 2019

Recruitment ongoing in phase I study of VSV-IFNb-TYRP1 for the treatment of melanoma

June 20, 2019

Cellular lung map gives asthma, other insights

June 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...